Related Experiment Video
Updated: Jul 16, 2026

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
Published on: June 15, 2016
Epstein-Barr virus transcription activator Rta upregulates decoy receptor 3 expression by binding to its promoter
Cheng-Hsun Ho1, Chen-Fang Hsu, Pei-Fen Fong
1Institute of Microbiology and Immunology, National Yang-Ming University, Number 155 Section 2 Linong Street, Taipei 112, Taiwan.
Abstract:
Decoy receptor 3 (DcR3) is a soluble decoy receptor belonging to the tumor necrosis factor receptor superfamily that is overexpressed in various malignant tumor types. DcR3 has been implicated in tumor cell survival by inhibiting apoptosis and by interfering with immune surveillance. A previous study showed that DcR3 expression is associated with Epstein-Barr virus (EBV)-positive lymphomas but rarely with non-EBV-positive B-cell lymphomas, suggesting that the presence of EBV may affect DcR3 expression. Here, we demonstrated enhanced DcR3 expression upon EBV reactivation in P3HR1 cells and in EBV-infected 293 cells. This enhancement, however, could not be detected in 293 cells infected with EBV with BRLF1 deleted. We found that EBV transactivator, Rta, could upregulate DcR3 expression by direct binding to an Rta-responsive element (RRE) located in the DcR3 promoter region and that this RRE is important for Rta-mediated DcR3 expression. Overexpressing CREB-binding protein (CBP) further enhanced Rta-dependent DcR3 expression, suggesting Rta-dependent DcR3 transcription activity is mediated by CBP. Previously, Rta was shown to enhance phosphatidylinositol-3 kinase (PI3-K) activity. However, Rta-transduced PI 3-K activity plays a minor role in DcR3 expression. This is the first report to demonstrate that Rta upregulates a cellular gene by direct binding to an RRE.
Insights
Epstein-Barr virus (EBV) reactivation enhances Decoy Receptor 3 (DcR3) expression. The EBV Rta protein directly binds the DcR3 promoter, upregulating its transcription, a process involving CREB-binding protein (CBP).
Area of Science:
- Virology
- Molecular Biology
- Immunology
Background:
- Decoy receptor 3 (DcR3) is a soluble receptor overexpressed in cancers, promoting tumor survival and immune evasion.
- DcR3 expression is linked to Epstein-Barr virus (EBV)-positive lymphomas, suggesting a role for EBV in its regulation.
Purpose of the Study:
- To investigate the mechanism by which EBV influences DcR3 expression.
- To identify the specific EBV components and cellular factors involved in DcR3 regulation.
Main Methods:
- EBV reactivation in P3HR1 and 293 cells.
- Analysis of DcR3 expression in EBV-infected cells, including those with deleted viral genes.
- Reporter assays to assess promoter activity and transcription factor binding.
- Western blotting and quantitative PCR to measure protein and gene expression.
Main Results:
- EBV reactivation significantly enhanced DcR3 expression in infected cells.
- Deletion of the EBV BRLF1 gene abolished this enhancement.
- The EBV Rta protein directly binds to an Rta-responsive element (RRE) in the DcR3 promoter, driving transcription.
- Co-expression of CREB-binding protein (CBP) potentiated Rta-mediated DcR3 upregulation.
- The role of Rta-enhanced PI3-K activity in DcR3 expression was found to be minor.
Conclusions:
- EBV Rta protein directly upregulates cellular DcR3 gene expression via binding to a specific RRE in its promoter.
- This Rta-mediated transcriptional regulation is dependent on CBP, highlighting a novel mechanism of viral gene control.
- These findings elucidate a direct link between EBV infection and the overexpression of a key cancer-associated decoy receptor.
Related Concept Videos
Co-activators and Co-repressors
Receptor Tyrosine Kinases
RNA Polymerase II Accessory Proteins
MAPK Signaling Cascades
Master Transcription Regulators
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
